Financial News
(OP: MDXXF )
0.1884
+0.0064
(+3.52%)
Streaming Delayed Price
Updated: 10:00 AM EST, Feb 14, 2025
Add to My Watchlist
All News about MDXXF
![](https://ml.globenewswire.com/media/20158980-8674-43e3-a0be-a10dca42410d/small/pharmala-biotech-logo-800-x-422-png.png)
PharmAla Signs Advisory Agreement with Mr. Matthew Azrieli
February 06, 2025
From PharmAla Biotech
Via GlobeNewswire
![](https://ml.globenewswire.com/media/20158980-8674-43e3-a0be-a10dca42410d/small/pharmala-biotech-logo-800-x-422-png.png)
![](https://cdn.benzinga.com/files/images/story/2024/10/21/3-5.png?width=1200&height=800&fit=crop)
![](https://ml.globenewswire.com/media/20158980-8674-43e3-a0be-a10dca42410d/small/pharmala-biotech-logo-800-x-422-png.png)
PharmAla to supply Mt. Sinai Hospital with LaNeo MDMA
October 21, 2024
From PharmAla Biotech
Via GlobeNewswire
![](https://cdn.benzinga.com/files/images/story/2024/10/08/3-2.png?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2024/10/02/2-1.png?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2024/09/11/1-10.png?width=1200&height=800&fit=crop)
![](https://ml.globenewswire.com/media/20158980-8674-43e3-a0be-a10dca42410d/small/pharmala-biotech-logo-800-x-422-png.png)
PharmAla Launches MDMA Clinical Trial Tool for Researchers
August 22, 2024
From PharmAla Biotech
Via GlobeNewswire
![](https://ml.globenewswire.com/media/20158980-8674-43e3-a0be-a10dca42410d/small/pharmala-biotech-logo-800-x-422-png.png)
![](https://cdn.benzinga.com/files/images/story/2024/05/29/MDMA-Psilocybin-Health-Canada-Cytonn-Pho.jpeg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2024/04/17/Psyched-New---option-1.jpeg?width=1200&height=800&fit=crop)
![](https://ml.globenewswire.com/media/20158980-8674-43e3-a0be-a10dca42410d/small/pharmala-biotech-logo-800-x-422-png.png)
![](https://cdn.benzinga.com/files/images/story/2024/Psyched-New---option-1_3.jpeg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2024/Psyched_3.png?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2024/MDMA-investigation-Yuriy-Golub-and-Bacsi.jpeg?width=1200&height=800&fit=crop)
PharmAla's Novel MDMA Mixture Awarded US Patent, Enabling IP Protection And Further Development
March 27, 2024
Via Benzinga
Topics
Intellectual Property
Exposures
Intellectual Property
![](https://ml.globenewswire.com/media/20158980-8674-43e3-a0be-a10dca42410d/small/pharmala-biotech-logo-800-x-422-png.png)
![](https://cdn.benzinga.com/files/images/story/2024/psychedelic-chemistry-Olia-Danilevich-by.jpeg?width=1200&height=800&fit=crop)
Via Benzinga
![](https://ml.globenewswire.com/media/20158980-8674-43e3-a0be-a10dca42410d/small/pharmala-biotech-logo-800-x-422-png.png)
![](https://ml.globenewswire.com/media/20158980-8674-43e3-a0be-a10dca42410d/small/pharmala-biotech-logo-800-x-422-png.png)
![](https://cdn.benzinga.com/files/images/story/2024/Psychedelics-deals-geralt--sergeitokmako.jpeg?width=1200&height=800&fit=crop)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.